<DOC>
	<DOCNO>NCT01553890</DOCNO>
	<brief_summary>The aim find presence anti vitamin D antibody scleroderma patient compare control . A second goal anti vitamin D level serum scleroderma patient relation clinical manifestation disease .</brief_summary>
	<brief_title>Empirical Comparative Study Variation Blood Level Antibody Vitamin D Scleroderma ( SSc ) Patients Compared Healthy Peoples</brief_title>
	<detailed_description>Blood sample 30 scleroderma patient compare 30 healthy people reach target variation blood level vitamin D antibody group</detailed_description>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Scleroderma , Localized</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>study group 1. patient SSc 2. age 18 year old old 3. sign ICF control group healthy people</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>SSc= scleroderma</keyword>
	<keyword>ICF+ inform consent form</keyword>
	<keyword>age 18 85</keyword>
	<keyword>healthy</keyword>
</DOC>